Bio-Techne Corporation (TECH) News
Track canonical SquawkNews coverage tagged to TECH, Bio-Techne Corporation. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 12 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover
Qiagen NV (NYSE: QGEN ) is drawing renewed investor attention after reports that several private equity firms are evaluating a potential takeover of the molecular diagnostics company. The stock surged 10.5% in the previo
MACRO | Jul 10, 2026, 01:26 PM UTC
L
TD Cowen Downgrades Bio-Techne to Hold, Raises Price Target to $73
TD Cowen analyst Kyle Boucher downgrades Bio-Techne (NASDAQ: TECH ) from Buy to Hold and raises the price target from $65 to $73.
EQUITY | Jun 30, 2026, 01:38 PM UTC
L
Benchmark Downgrades Bio-Techne to Hold
Benchmark analyst Robert Wasserman downgrades Bio-Techne (NASDAQ: TECH ) from Buy to Hold.
EQUITY | Jun 30, 2026, 01:18 PM UTC
H
Bio-Techne, Merck KGaA Set Termination Fees
Bio-Techne to pay $230.5M termination fee to Merck KGaA if deal isn't consummated, while Merck KGaA to pay $576.1M if deal is terminated
EQUITY | Jun 26, 2026, 10:12 AM UTC
M
12 Health Care Stocks Move
Multiple health care stocks are moving in Thursday's intraday session, with gainers including Atlantic International and SELLAS Life Sciences, and losers including Nano X Imaging and Passage Bio
EQUITY | Jun 25, 2026, 05:05 PM UTC
H
Merck Buys Bio-Techne
Merck KGaA agrees to acquire Bio-Techne Corporation in an all-cash transaction valued at approximately $11.3 billion
EQUITY | Jun 25, 2026, 01:34 PM UTC
H
US Stocks: Premarket Movers
US stocks are moving premarket, with WYY up 45% and TECH up 19% on acquisition news, while ELME falls 28% on terminated agreement
EQUITY | Jun 25, 2026, 12:53 PM UTC
H
TECH Acquires Bio-Techne
Merck KGaA agrees to acquire Bio-Techne, strengthening its leadership position in life sciences markets
EQUITY | Jun 25, 2026, 12:04 PM UTC
H
Merck KGaA Acquires Bio-Techne
Merck KGaA to acquire Bio-Techne for $73 per share in cash, representing a total enterprise value of approximately $11.3 billion
EQUITY | Jun 25, 2026, 10:21 AM UTC
H
Merck Acquires Bio-Techne
Merck KGaA agrees to acquire Bio-Techne, strengthening its leadership position in life sciences markets
EQUITY | Jun 25, 2026, 10:11 AM UTC